CompletedPhase 1

Antibacterial and Anti-biofilm Activity of Frankincense Extract Against Porphyromonas Gingivalis

Egypt30 participantsStarted 2021-01-15

Plain-language summary

Boswellia sacra Flueck. oleoresin extract (frankincense) was traditionally used in the treatment of different diseases as respiratory, rheumatoid arthritis, and bacterial infections. Therefore, the antibacterial and antibiofilm activity of frankincense extract against Porphyromonas gingivalis periodontal pathogen clinical isolates were studied

Who can participate

Age range25 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients with grade III stage b periodontitis , patients who have the willing to participate in the study and informed consents will be taken from them Exclusion Criteria: * patients who are under antibiotic therapy or any antimicrobial drugs * smokers

What they're measuring

isolation of the p. gingivalis

Timeframe: at day zero for in vitro study

Trial details

NCT IDNCT04705714

SponsorTanta University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-03-01

View on ClinicalTrials.gov More Periodontal Diseases trials